Diabetes Mellitus Clinical Trial
Official title:
Analisys of Neuromuscular Response, Postural Balance and Quality of Life of Diabetics Type 2 After Sensory-motor Training: Blind Random Controled Clinical Trial
Background: The individual's ability to sustain itself in the upright position, effectively
adjusting the body's movements and reacting to external stimuli, postural control strategies
represent essential activities of daily living. Diabetes mellitus type 2 (DM-2) is
considered a more problem of Public Health as having complications deficit in functional
performance of the lower limbs and falls, which can interfere with the maintenance of
balance, and is a strong predictor of functional limitations self referred. Aim: To assess
quality of life and the answers neuromuscular balance and baropodometric after sensory-motor
training in patients with type 2 diabetes. Method: To be recruited 50 volunteers aged
between 45 to 64 years with DM-2, of both sexes, divided into two groups: 1) Guidelines and
2) Guidelines + sensory-motor training. Biomechanical data will be collected (balance,
baropodometry, electromyography strength and joint position sense), as well as
questionnaires ADDQoL and BESTest. The intervention will be twice a week for 45 minutes for
12 weeks, divided into three phases: heating, sensory-motor training and cool-down, with
monitoring of blood pressure and blood glucose. There will be a follow up after 3 months of
intervention. Statistical analysis will be used normality test to verify the data
distribution and consistent statistical test for the appropriate comparisons within and
between groups, and adopted a significance level of 5%. Expected Results: Considering
previous studies that demonstrate improvement in postural balance static and dynamic
responses under the forward training protocol sensorimotor disease Diabetes mellitus type 2,
is expected to improve neuromuscular, balance, distribution plant, the joint position sense
and the quality of life of voluntary DM-2.
Keywords: physical therapy modalities, exercise therapy, postural balance, Diabetes
Mellitus, quality of life.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |